Fact Check: Preprint Claiming 84.4% 'Clinical Benefit' of Ivermectin, Mebendazole In Cancer Treatment Is NOT A Proper Clinical Trial
Fact Check
Is a paper by Dr. Drew Pinsky, Dr. Peter McCullough, Dr. Harvey Risch, and nine others claiming that ivermectin and mebendazole improve cancer outcomes in 84.4% of cases a proper medical study? No, that's not true: Research experts told Lead Stories that the paper relies on an uncontrolled, self-reported survey with major bias, no independent verification of diagnoses or outcomes,…